Test designed for early diagnosis, monitoring and cancer relapse detection in dogs. Read more
Tested material:
This is the world’s first minimal residual disease (MRD) test specifically tailored for dogs. This cutting-edge, liquid biopsy-based tool offers a noninvasive, reliable solution for early diagnosis and cancer relapse detection, revolutionizing how veterinarians approach cancer care.
Vet Expert K9-LiquiDX Canine Cancer Check test result is then presented in the form of a detailed report, offering valuable insights for early diagnosis, treatment planning, and monitoring of cancer progression or relapse.
EARLY DETECTION: Detect cancer and potential relapses before they show clinical signs.
EARLY INTERVENTION: Initiate treatment earlier for better outcomes and prolonged quality of life.
PRECISION MONITORING: High-precision results enable targeted, personalized treatment strategies based on each animals genetic profile.
COMPREHENSIVE FINAL REPORT: Access detailed genetic data that ensures more accurate and effective treatment plans.
NO SEDATION REQUIRED: Most patients can undergo the procedurę with no sedation or anesthesia.
ADVANCED CARE: Position your clinic at the forefront of veterinary medicine by offering this innovative, minimally-invasive cancer detection technology.
IMPROVE TRUST: Pet owners will value your commitment to their pet’s health with such state-of-the-art diagnostics.
INCREASE REVENUE: Offer more treatment options and earlier relapse detection, enhancing both patient outcomes and clinic revenue.
Box: 1 set
Complete set includes:
Special box with UN3373 marking, dedicated for transporting the sample
Special sampling tube (sampling vial) with stabilizer intended for the collection of the whole blood sample from patient
ShuttlePouch, dedicated for packing and protecting of the sample tube filled with the whole blood sample
Other products for Veterinary diagnostics for Dogs
